首页> 外文期刊>Annals of Surgery >Cost of Major Complications After Liver Resection in the United States
【24h】

Cost of Major Complications After Liver Resection in the United States

机译:美国肝切除后主要并发症的成本

获取原文
获取原文并翻译 | 示例
       

摘要

Supplemental Digital Content is available in the text Objective: The aim of the study was to estimate the cost of major complications after liver resection and determine whether high-volume (HV) centers are cost-effective. Methods: From 2002 to 2011, 96,107 cases of liver resection performed in the United States were identified using Nationwide Inpatient Sample. Hospitals were categorized as HV (150+ cases/yr), medium-volume (51–149?cases/yr), and low-volume (LV) (1–50?cases/yr) centers. Multivariable regression analysis identified predictors of cost. Propensity score matching comparing cases with versus without complications and costs of specific complications were estimated. Cost-effectiveness of HV centers was determined by calculating the incremental cost-effectiveness ratio. Results: After propensity score matching, the occurrence of a major complication added $33,855 extra cost, increased mean length of stay by 8.7 [95% confidence interval (CI), 8.4–9] days and increased risk of death by 9.3% (all P < 0.001). The cost of most common complications was wound infection (3.8%, $21,995), renal failure (2.8%, $19,201), respiratory failure (2.7%, $25,169), and hemorrhage (3.3%, $9,180), whereas sepsis (0.8%, $33,009), gastrointestinal bleeding (0.5%, $32,835), fistula (0.2%, $27,079), and foreign body removal (0.1%, $29,404) were most costly, but less frequent. Compared with LV centers, liver resection at HV centers was associated with $5109 (95% CI, 4409–5809, P < 0.001) more cost per case, yet on average 0.54 years (95% CI, 0.23–0.86) longer survival for an incremental cost-effectiveness ratio of $9392. Conclusions: HV centers were cost-effective at performing liver resection compared with LV centers. After liver resection, complications such as surgical site infection, respiratory failure, and renal failure contributed the most to annual cost burden.
机译:补充数字内容在案文中提供:该研究的目的是估算肝切除后主要并发症的成本,并确定高批量(HV)中心是否具有成本效益。方法:从2002年到2011年,在美国在美国进行了96,107例,在美国进行了在美国进行的肝脏切除术例。医院被归类为HV(150多种病例/ YR),中体积(51-149?病例/ YR)和低容量(LV)(1-50个?案例/年)中心。多变量回归分析确定了成本的预测因子。估计倾向评分与未经并发症和特定并发症成本的比较案例匹配。通过计算增量成本效益率来确定HV中心的成本效益。结果:经过倾向得分匹配后,主要并发症的发生增加了33,855美元的额外成本,增加了平均入住时间8.7 [95%置信区间(CI),8.4-9]天,降低死亡风险增加9.3%(所有P <0.001)。最常见并发症的成本是伤口感染(3.8%,21,995美元),肾功能衰竭(2.8%,19,201美元),呼吸衰竭(2.7%,25,169美元)和出血(3.3%,9,180美元),而败血症(0.8%,33,009美元) ),胃肠道出血(0.5%,32,835美元),瘘管(0.2%,27,079美元)和异物去除(0.1%,29,404美元)最昂贵,但越来越少。与LV中心相比,HV中心的肝切除与5109美元(95%CI,4409-5809,P <0.001)的成本更高,但平均为0.54岁(95%CI,0.23-0.86)的生存更长增量成本效益率为9392美元。结论:与LV中心相比,HV中心在表演肝切除方面具有成本效益。在肝切除后,并发症如外科手术部位感染,呼吸衰竭和肾功能衰竭促使年度成本负担最多。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号